Pharma Journalist 8801 posts 0 comments

Evotec SE announced that the Company received a US$ 6 m payment from Bristol-Myers Squibb Company following the decision to expand the collaboration to include additional cell lines.…
Read More...

Altavant Sciences announced that it has entered into a definitive agreement to acquire Onspira Therapeutics, a private drug development company similarly focused on therapeutics for…
Read More...

MercachemSyncom announced that it has acquired Alcami’s European cGMP CMC drug substance development site, based in Weert, the Netherlands. The acquisition will allow MercachemSyncom to…
Read More...

Schrödinger and Bayer announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative…
Read More...

Immunic, Inc. announced that its subsidiary, Immunic AG, under the terms of its existing option and license agreement with Daiichi Sankyo Co., Ltd. (hereinafter, Daiichi Sankyo), has…
Read More...

Catabasis Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, and Duchenne UK, a charity that seeks to fund and accelerate treatments and a cure for Duchenne muscular…
Read More...

Avacta Group plc and Daewoong Pharmaceutical Co. Ltd. announced that they have agreed to establish a joint venture in South Korea, and to enter a collaboration and license agreement for…
Read More...

Candel Therapeutics announced that it has acquired all oncolytic and other Herpes Simplex Virus (HSV) based assets from PeriphaGen, Inc., bringing its vector engineering, production…
Read More...

Galecto, the leading developer of galectin modulators for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF) and cancer, and PharmAkea, Inc., a privately…
Read More...

Curis, Inc. announced that it has entered into an option and license agreement to acquire exclusive, worldwide rights from ImmuNext Inc. (ImmuNext) to develop and commercialize…
Read More...